Abstract

Contents

• NIHR Health Technology Assessment programme
• List of abbreviations
• Executive summary
• 1. Background
  • Description of the health problem (glaucoma)
  • Ocular hypertension as a risk factor for open-angle glaucoma
  • Impact of the health problem
  • Current service provision
  • Current service cost
  • Variation in services
  • Uncertainties regarding best practice for managing ocular hypertension
• 2. Aim and objectives
  • Aim
  • Objectives
• 3. Materials
  • Overview of searching for the evidence
  • Description of individual patient data sets
• 4. Risk prediction tools for development of open-angle glaucoma
  • Introduction
  • Aims
  • Methods
  • Results
  • Discussion
  • Conclusions
• 5. Agreement and reliability of candidate tonometers for measuring intraocular pressure
  • Introduction
  • Aim and objectives
  • Methods
  • Results
  • Discussion
  • Conclusions
• 6. Optimal frequency of monitoring of intraocular pressure and visual fields
  • Introduction
  • Objectives
  • Methods
  • Results
  • Discussion
  • Conclusions
• 7. Eliciting preferences for alternative monitoring services using a discrete choice experiment
  • Background
  • Objectives
  • Developing the discrete choice experiment
  • Sample, pilot and main data collection
  • Econometric analysis
  • Results
  • Discussion
  • Conclusions
• 8. Economic evaluation
  • Systematic review of economic evaluations of ocular hypertension surveillance programmes
  • Economic evaluation of surveillance pathways for individuals with ocular hypertension
  • Discussion and summary
  • Conclusions
• 9. Discussion
  • Summary of main findings
  • Strengths and limitations
• 10. Conclusions
  • Implications for health care
  • Implications for research
• Acknowledgements
• References
• Appendix 1 Search strategies
• Appendix 2 List of excluded full-text studies
• Appendix 3 Characteristics of the included studies (Chapter 5)
• Appendix 4 Systematic review of the agreement and reliability of tonometers: further analysis (Chapter 5)
• Appendix 5 Recordability data by tonometer (Chapter 5)
• Appendix 6 Acceptability/practicality data by tonometer (Chapter 5)
• Appendix 7 Reliability data by tonometer (Chapter 5)
• Appendix 8 Using statistical models to develop monitoring criteria (Chapter 6)
• Appendix 9 Optimal frequency of monitoring intraocular pressure and visual fields: further analysis (Chapter 6)
• Appendix 10 Systematic review of economic evaluations of surveillance strategies for ocular hypertension: methods and results (Chapter 8)
• Appendix 11 Project protocol
• Health Technology Assessment programme

Suggested citation:

Burr JM, Botello-Pinzon P, Takwoingi Y, Hernández R, Vazquez-Montes M, Elders A, et al. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation. Health Technol Assess 2012;16(29).

Suggested citation:

Rodgers M, Asaria M, Walker S, McMillan D, Lucock M, Harden M, et al. The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review. Health Technology Assessment, 2012;16(28).

Declaration of competing interests: none

The research reported in this issue of the journal was commissioned by the HTA programme as project number 07/46/02. The contractual start date was in February 2009. The draft report began editorial review in June 2011 and was accepted for publication in November 2011. As the funder, by devising a commissioning brief, the HTA programme specified the research question and study design.The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the referees for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.

The views expressed in this publication are those of the authors and not necessarily those of the HTA programme or the Department of Health.